NCT05876585View on ClinicalTrials.gov

Clinical Trial to Investigate the Efficacy and Safety of Ondansetron (Danset - Adwia) Versus Placebo Plus the Standard of Care in the Treatment of Nausea and Vomiting in Adult Patients With Acute Gastroenteritis

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

126

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

June 1, 2025

Study Completion Date

June 1, 2025

Conditions
Gastroenteritis
Interventions
DRUG

Ondansetron 8 mg ampoule

Study drug

DRUG

Metoclopramide 10 mg ampoule

Comparator drug

Sponsors

Collaborators (1)

Adwia Pharma, Egypt
All Listed Sponsors
collaborator

Adwia Pharma, Egypt

UNKNOWN

lead

Genuine Research Center, Egypt

INDUSTRY

NCT05876585 - Clinical Trial to Investigate the Efficacy and Safety of Ondansetron (Danset - Adwia) Versus Placebo Plus the Standard of Care in the Treatment of Nausea and Vomiting in Adult Patients With Acute Gastroenteritis | Biotech Hunter | Biotech Hunter